Advertisement
Screener

X4 PHARMACEUTICALS, INC (XFOR) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

X4 PHARMACEUTICALS, INC Cash Flow Breakdown

Cash flow breakdown shows where X4 PHARMACEUTICALS, INC's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $85.62M went out.
  • Fiscal year ended 2025-12-31: from investing, $8.15M came in.
  • Fiscal year ended 2025-12-31: from financing, $238.63M came in.
  • Fiscal year ended 2025-12-31: change in cash, $161.38M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$85.62M$8.15M$0.00$238.53M$161.38M
2024-12-31-$130.90M$66.99M$0.00$0.00$0.00$20.29M*-$43.77M
2023-12-31-$96.51M-$14.88M$0.00-$2.06M$0.00$60.00M$30.58M*-$22.78M
2022-12-31-$77.10M-$103.00K$0.00-$795.00K-$12.00K$118.04M*$39.92M
2021-12-31-$70.91M-$615.00K-$2.00M$0.00$0.00$76.25M*$2.41M
2020-12-31-$58.82M-$1.36M$0.00$0.00-$278.00K$12.67M*-$47.38M
2019-12-31-$48.05M$27.23M$0.00-$9.37M$0.00$150.03M*$119.59M
2018-12-31-$25.42M$0.00-$6.38M$0.00$179.00K$13.07M*-$18.55M
2017-12-31-$21.31M-$378.00K$0.00$694.00K$32.73M*$11.73M
2016-12-31-$21.64M-$73.00K-$250.00K$514.00K$17.88M*-$3.67M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$20.79M*-$1.00M*$74.00K*
2026-03-31-$19.60M$19.25M$2.00K-$365.00K
2025-12-31-$15.53M*$16.85M*$146.04M*
2025-09-30-$27.82M*-$28.67M*$86.91M*
2025-06-30-$29.90M*$23.11M*$46.00K*$5.58M*
2025-03-31-$12.37M-$3.14M$0.00-$15.43M
2024-12-31-$32.99M*-$8.62M*$0.00*
2024-09-30-$34.03M*-$15.93M*$0.00*
2024-06-30-$63.90M$96.86M*$20.16M*
2024-03-31-$33.60M-$5.32M-$38.98M
2023-12-31-$27.75M*-$4.83M*$0.00*$51.38M*
2023-09-30-$68.80M-$5.16M*$0.00*$2.00K*$21.20M*
2023-06-30-$47.90M-$4.88M*$0.00*$69.34M*
2023-03-31-$26.51M-$9.00K-$443.00K$0.00-$1.68M*-$28.59M
2022-12-31-$19.09M*-$34.00K*$0.00*$0.00*$60.64M*
2022-09-30-$19.31M*-$9.00K*$0.00*$0.00*$51.98M*
2022-06-30-$18.47M*-$38.00K*$0.00*
2022-03-31-$20.23M-$22.00K-$12.00K$4.97M*-$15.36M
2021-12-31-$19.05M*-$13.00K*$0.00*$0.00*$24.57M*
2021-09-30-$14.21M*-$20.00K*$0.00*$0.00*-$4.44M*
2021-06-30-$19.20M*-$86.00K*$0.00*$0.00*-$924.00K*
2021-03-31-$18.44M-$496.00K$0.00$0.00$55.04M*$35.96M
2020-12-31-$17.50M*-$302.00K*$0.00*$0.00*$0.00*$7.63M*
2020-09-30-$14.33M*-$496.00K*$0.00*$0.00*-$264.00K*
2020-06-30-$11.46M*-$9.00K*$0.00*
2020-03-31-$15.53M-$555.00K$4.89M-$11.13M
2019-12-31-$9.24M*$21.00K*$0.00*$0.00*$60.28M*
2019-09-30-$12.77M*$815.00K*-$6.45M*$0.00*$0.00*
2019-06-30-$14.29M*-$10.00K*$9.85M*$76.83M*
2019-03-31-$11.75M$26.41M$0.00$113.00K$14.75M
2018-12-31-$6.73M*$0.00*-$4.88M*$27.00K*$9.88M*
2018-09-30-$6.72M*$27.00K*-$500.00K*$0.00*$4.50M*
2018-06-30-$5.78M*-$500.00K*
2018-03-31-$6.18M-$500.00K-$1.16M*-$7.84M
2017-12-31-$6.35M*-$319.00K*$1.75M*$9.00K*-$11.25M*
2017-09-30-$5.09M*-$18.00K*-$585.00K*$19.00K*$4.21M*
2017-03-31-$3.51M-$17.00K-$582.00K$4.92M*$820.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
Liminatus Pharma, Inc. (LIMN)United States$0.282B
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Invivyd, Inc. (IVVD)United States$0.270B-2.42
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Ocugen, Inc. (OCGN)United States$0.343B-6.34